ProCE Banner Activity

Guidance on Biomarker-Driven Therapeutic Approaches in Gastrointestinal Cancers


Download this slideset featuring expert perspectives on the latest in biomarker testing and the use of targeted therapeutics in gastrointestinal cancers.

Released: July 24, 2023



James M. Cleary

James M. Cleary, MD, PhD

Associate Professor of Medicine
Harvard Medical School
Director of Clinical Research
Gastrointestinal Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by educational grants from Bayer HealthCare Pharmaceuticals Inc. and Merck Sharp & Dohme LLC.

Bayer HealthCare Pharmaceuticals Inc.

Merck Sharp & Dohme, LLC